Clinical trial tech company Unlearn scored $50 million in a Series B financing round led by Insight Partners.
Other participants in the round include Radical Ventures, 8VC, DCVC, DCVC Bio and Mubadala Capital Ventures. According to Crunchbase, Unlearn's total raise now totals nearly $70 million.
Unlearn uses a machine learning model to create digital twins of randomized controlled trial...